On Thursday, ETSY, (NASDAQ:ETSY)’s shares skyrocketed 87.50% to $30, hitting its highest level.
Nasdaq (NDAQ) declared that trading of Etsy, Inc. (ETSY) commenced on The Nasdaq Stock Market on April 16, 2015.
By listing with Nasdaq, Etsy joins many of the world’s largest and most revolutionary companies. Nasdaq has been the exchange of choice to over 70 percent of technology companies listed in the U.S. markets.
On April 15, Etsy, declared the pricing of its initial public offering of 16,666,666 shares of its common stock at a price to the public of $16.00 per share. The offering is predictable to close on April 21, 2015, subject to customary closing conditions.
Etsy is offering 13,333,333 shares and selling stockholders are offering 3,333,333 shares. Etsy will not receive any proceeds from the sale of shares by the selling stockholders. In addition, selling stockholders have granted the underwriters a 30-day option to purchase up to 2,499,999 additional shares.
Goldman, Sachs & Co. and Morgan Stanley & Co. LLC are acting as joint book-running managers for the offering. Allen & Company LLC, Loop Capital Markets LLC and The Williams Capital Group, L.P. are acting as co-managers.
Etsy is a marketplace where millions of people around the world connect, both online and offline, to make, sell and buy unique goods. The Etsy ecosystem comprises entrepreneurs who sell on our platform, consumers looking to buy unique goods in our marketplace, manufacturers who assist Etsy sellers grow their businesses and Etsy employees who maintain our platform. Etsy was founded in 2005 and is headquartered in Brooklyn, New York.
MediciNova Inc. (NASDAQ:MNOV)’s shares surged 41.31% to $4.96, during the last trading session on Thursday, hitting its highest level, as a biopharmaceutical company, declared that the Food and Drug Administration granted the company’s treatment for nonalcoholic steatohepatitis with fibrosis, tipelukast, fast track designation.
Fast track designation is designed to assist expedite the review process for drugs being developed to treat potentially fatal or serious diseases that do not have a viable alternative treatment already.
“We are very happy that MN-001 has received Fast Track designation and believe this validates its potential to address unmet medical needs in this life-threatening disease. We look forward to providing further updates as our development progresses,” said CEO Yuichi Iwaki, MD, PhD.
MediciNova, Inc., a biopharmaceutical company, focuses on acquiring and developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs for the United States market.
At the end of Thursday’s trade, Workday, Inc. (NYSE:WDAY)’s shares gained 1.75% to $89.72.
Workday, declared that the San Francisco Business Times and the Silicon Valley / San Jose Business Journal ranked Workday #1 for the largest companies on its annual list of Best Places to Work in the Bay Area. This marks the fourth time that Workday has ranked #1 and is the eighth successive year Workday has appeared on the list. Workday just celebrated its 10th anniversary in March with more than 3,700 employees around the world.
Employees from nearly 300 Bay Area companies take partd in an independent, third-party survey, ranking their companies on topics counting work culture, administration practices, trust with coworkers, benefits, overall compensation, longevity, trust in senior leaders, and feeling valued.
This latest recognition follows other honors Workday has received as a top workplace in the U.S. and Europe in the past year:
- Ranked #22 by Fortune magazine on its list of the 100 Best Companies to Work For
- Ranked #1 in the large companies category by the Great Place to Work Institute on its People’s Picks: 20 Top Workplaces in Technology list
- Named the #1 Top Workplace in the Bay Area for large companies for the fourth successive year by the Bay Area News Group
- Named a Best Workplace in Ireland by the Great Place to Work Institute for medium-sized companies.
Workday, Inc. provides enterprise cloud applications for finance and human resources in the United States and internationally. It offers applications for customers to manage critical business functions that enable them to optimize their financial and human capital resources.
Finally, Office Depot, Inc. (NASDAQ:ODP), ended its Thursday’s trading session with 1.73% gain, and closed at $9.41.
Office Depot, which reached a definitive contract on February 4, 2015 to be attained by Staples Inc., offers historical insight and gift suggestions to assist celebrate Administrative Professionals Day on April 22.
There are more than three million administrative professionals in the workforce recently and an predictable twelve percent raise in projected employment through 2022. According to today’s administrative professionals, office administration, travel planning, meeting planning, project administration and online purchasing are the top five tasks that have become more important over the past two years.
According to an infographic on Office Depot’s Business Solutions Center, an interactive small business online resource, a public relations executive named Harry Klemfuss originated the idea for National Secretaries Week. The week, which later became Administrative Professionals Day, began as a way to recognize and call attention to secretaries’ skills, loyalty and efficiency.
Lord identifies several products that show appreciation for administrative professionals counting furniture such as an ergonomically correct desk chair, new computer hardware and software, as well as desk accessories, such as the See Jane Work® collection.
Office Depot, Inc., together with its auxiliaries, supplies office products and services. The company’s North American Retail division sells an assortment of merchandise, counting office supplies, technology products and solutions, business machines and related supplies, facilities products, and office furniture under various brands through its chain of office supply stores.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
